Member Info for Uncanny

Its all speculation as we expect positive news but how good or average will it be?

Perhaps mention this in advance of the AGM?

The honest answer is, nobody knows Freddy. I’ve averaged down so many times and in the same boat as you, considering whether one more bite of the cherry or stay put. I am hoping for a good update pre-agm to calm SH nerves and get back to over a £10mn market cap where we should be realistically if all the science works as we are told. Apart from the BoD and connected parties, who knows on 401 deal progress and 201 CT1/2 outcome.

No they will sell it at P2

What a load of desperate rubbish! You boys are going to get smashed. Enjoy the weekend!9

Rosee, you think VAL will hold back at least a one liner as an inkling as to how 201 has gone to simply say things are good pre-AGM? You’d be an idiot to think otherwise, unless other inflection points but they can’t possibly expect to get their way at the AGM without a shareholder sweetener.

The RNS didn’t say that - results this month, analysis next quarter. Exciting times!

“The results from the trial are expected at the end of H1 2019 and analysis of the data is anticipated to start Q3 2019, following which a full analysis of the results and findings will be published. “

Not quite right Roses The 8 bag on 401 was Dec 2017 after positive results: https://www.valirx.com/video/valirx-unveils-positive-results-val401-phase-ii-lung-cancer-trial/ The final published clinical trials were Nov 2018 http://tools.euroland.com/tools/PressReleases/GetPressRelease/?ID=3527057&lang=en-GB&companycode=services

The full analysis is 3rd quarter but they must know what they have now and a what the optimum dosage and frequency is likely to be. An interim FNS is what we are waiting for.

I thought it was 30% PSA reduction at 4mg/kg not greater than 30%! That is quite a different matter, so what after escalating the dosage and frequency from 4-16mg/kg?

What l have just gleaned surprised me re: 201 on 4mn: “PSA response data for pt # 101-008 ) with metastatic castrate resistant prostate cancer, a >30% PSA response on low dose and low frequency of dosing.“ GREATER THAN 30%! What will 4-16mg produce and where is the optimum dosing?

Caveat Emptor, refreshing posts and looks like ADVFN more upbeat as well now, if you resd the posters here. My gut feeling is if 201 is as expected, the rise will shadow 401 in Dec 17 as its importance and commerciality is much more significant. Tolerable, no side effects, orally administered, 25 year safety record etc, in a potential $17 billion marker: https://www.globenewswire.com/news-release/2018/09/24/1575060/0/en/Global-Prostate-Cancer-Therapeutics-Market-Will-Reach-USD-17-200-Million-By-2024-Zion-Market-Research.html

Good post Caveat

But Scooby, apart from salaries yes, whats in it for them? I would think Suzy wants something from her 7.5% stake 401 stake and if the compounds are as good a stated, then the company can derive so much more as VAL on the open market with large pharma's, plus the IP licenseS belongs to VAL, i.e. you and me etc. Any siphoning off of IP is easily traceable.

Maybe they have a LoI for 201 and need to just fund until EO 2019?

I agree within next 2 weeks we SHOULD get something? 201 concludes is it today or next week (?), so an update on this is what l am expecting unless 401 has something to add or could it be a general product update on all and sundry?

401 - where are we? 201 - l say IF we get good results, what we do know is that this may be accelerated to P3 and must surely be worth an 8 - 9 figure sum for VAL by a willing large pharma. Now l hope this is what Teamhanz is referring to in the next 2 - 6 weeks?

Strong words Fred and fair comment. Thats the dilemma - the science is great, the balance sheet isn’t so something has to give - sell IP for a multi-bag or is it lights off time. If the conspiracy is to run the company in to the ground to take the IP in an orchestrated plan then the BoD will be in court quicker than they can scratch their asses! Now where is Teamhanz and our exciting news? I certainly hope you are right.

Hi Freddie, as one of a handful of genuine posters l am trying to remain upbeat as the two unknowns are 201 - how average or outstanding and 401, has SEEK dine the deal? On the downside we have a shxte funding situation, but that could be resolved if the above comes home to roost. VAL / UCLR will know what they have already and it would be suicidal to go to the AGM not armed with some positive updates / deals etc.